Top compounds associated with response to LMNTD2

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	Epothilone B	GDSC1000	pan-cancer	AAC	-0.073	0.04
mRNA	TL-2-105	GDSC1000	pan-cancer	AAC	-0.068	0.04
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.075	0.04
mRNA	sirolimus:bortezomib (250:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.069	0.04
mRNA	BRD-A02303741:carboplatin (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.077	0.04
mRNA	KIN001-135	GDSC1000	pan-cancer	AAC	0.11	0.04
mRNA	Nilotinib	GDSC1000	pan-cancer	AAC	-0.075	0.04
mRNA	Cisplatin	GDSC1000	pan-cancer	AAC	-0.07	0.05
mRNA	masitinib	GDSC1000	pan-cancer	AAC	-0.065	0.05
mRNA	CHEMBL1222381	CTRPv2	pan-cancer	AAC	0.065	0.05

Download CSV